Absence of detectable xanthine oxidase in human myocardium
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 21 (3) , 263-267
- https://doi.org/10.1016/0022-2828(89)90741-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Purine efflux after cardiac ischemia: relevance to allopurinol cardioprotectionAmerican Journal of Physiology-Heart and Circulatory Physiology, 1987
- Absence of xanthine oxidase or xanthine dehydrogenase in the rabbit myocardiumBiochemical and Biophysical Research Communications, 1986
- Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated heartsThe Journal of Thoracic and Cardiovascular Surgery, 1986
- Effect of allopurinol on neutrophil superoxide production, chemotaxis, or degranulationBiochemical Pharmacology, 1985
- Involvement of hydrogen peroxide and hydroxyl radical in the ‘oxygen paradox’: Reduction of creatine kinase release by catalase, allopurinol or deferoxamine, but not by superoxide dismutase**Journal of Molecular and Cellular Cardiology, 1985
- Xanthine oxidase as a source of free radical damage in myocardial ischemiaJournal of Molecular and Cellular Cardiology, 1985
- High concentrations of antibodies to xanthine oxidase in human and animal sera. Molecular characterization.Journal of Clinical Investigation, 1984
- Measurement of Xanthine Oxidase Activity in Some Human TissuesEnzyme, 1983
- Serum Xanthine Oxidase: A Sensitive Test of Acute Liver InjuryGastroenterology, 1965
- XANTHINE OXIDASE ACTIVITY IN HUMAN TISSUES AND ITS INHIBITION BY ALLOPURINOL (4-HYDROXYPYRAZOLO[3,4-D] PYRIMIDINE)1965